Hepatitis C virus infection in intravenous drug users
Open Access
- 1 August 2004
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (8) , 768-770
- https://doi.org/10.1111/j.1469-0691.2004.00934.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Severity and correlates of liver disease in hepatitis C virus-infected injection drug usersHepatology, 2002
- Managing chronic hepatitis C acquired through intravenous drug useQJM: An International Journal of Medicine, 2001
- Prevalence and Distribution of Hepatitis C Subtypes in Patients with Opioid DependenceEuropean Addiction Research, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Clinical outcome of hepatitis C as a function of mode of transmissionHepatology, 1998
- The Importance of Preventing Hepatitis C Virus Infection Among Injection Drug Users in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Histological Classification and Quantitation of the Severity of Chronic Hepatitis: Keep It Simple!Seminars in Liver Disease, 1995
- The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. Intravenous drug useHepatology, 1993
- Viral Hepatitis and Drugs: A Continuing ProblemInternational Journal of Epidemiology, 1993
- ANTIBODY TO HEPATITIS C VIRUS IN GERMAN BLOOD DONORSThe Lancet, 1989